BRPI0408518A - terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2 - Google Patents

terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2

Info

Publication number
BRPI0408518A
BRPI0408518A BRPI0408518-3A BRPI0408518A BRPI0408518A BR PI0408518 A BRPI0408518 A BR PI0408518A BR PI0408518 A BRPI0408518 A BR PI0408518A BR PI0408518 A BRPI0408518 A BR PI0408518A
Authority
BR
Brazil
Prior art keywords
inhibitor
nemorubicin
cyclooxygenase
combination therapy
cox
Prior art date
Application number
BRPI0408518-3A
Other languages
English (en)
Inventor
Maria Cristina Geroni
Maria Adele Pacciarini
Antonino Suarato
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Publication of BRPI0408518A publication Critical patent/BRPI0408518A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"TERAPIA COMBINADA COMPREENDENDO NEMORUBICIN E UM INIBIDOR DE CICLOOXIGENASE-2". A presente invenção refere-se ao uso de um derivado de morfolinil antraciclina, um sal farmaceuticamente aceitável ou metabólito do mesmo, para a preparação de um medicamento em combinação com um inibidor de Cox-2, para uso simultâneo, separado ou seqüencial em tratamento de câncer, e a composições ou unidades embaladas compreendendo um derivado de morfolinil antraciclina e um inibidor de Cox-2.
BRPI0408518-3A 2003-03-18 2004-03-04 terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2 BRPI0408518A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03075780 2003-03-18
PCT/EP2004/050251 WO2004082689A1 (en) 2003-03-18 2004-03-04 Combined therapy comprising nemorubicin and a cyclooxygenase-2-inhibitor

Publications (1)

Publication Number Publication Date
BRPI0408518A true BRPI0408518A (pt) 2006-03-07

Family

ID=33016930

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0408518-3A BRPI0408518A (pt) 2003-03-18 2004-03-04 terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2

Country Status (6)

Country Link
EP (1) EP1605951A1 (pt)
AU (1) AU2004222527A1 (pt)
BR (1) BRPI0408518A (pt)
CA (1) CA2519310A1 (pt)
MX (1) MXPA05009849A (pt)
WO (1) WO2004082689A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2240495B1 (en) 2008-02-01 2015-07-15 Genentech, Inc. Nemorubicin metabolite and analog reagents, antibody-drug conjugates and methods
CA2721140C (en) 2008-04-11 2016-02-09 Tianjin Hemay Bio-Tech Co. Ltd. Tetracyclic anthraquinone antibiotic derivatives with high activity, process for preparing the same and use thereof
KR101328315B1 (ko) 2008-04-11 2013-11-11 티안진 헤메이 바이오-텍 컴퍼니 리미티드 고활성의 안트라사이클린 항생물질 유도체, 이의 제조방법 및 사용
AU2009270988A1 (en) 2008-07-15 2010-01-21 Genentech, Inc. Anthracycline derivative conjugates, process for their preparation and their use as antitumor compounds
KR101897307B1 (ko) * 2010-12-02 2018-09-10 네르비아노 메디칼 사이언시스 에스.알.엘. 모르폴리닐 안트라사이클린 유도체의 제조 방법
WO2016040825A1 (en) 2014-09-12 2016-03-17 Genentech, Inc. Anthracycline disulfide intermediates, antibody-drug conjugates and methods
AU2015326407C1 (en) * 2014-10-03 2021-06-24 Engeneic Molecular Delivery Pty Ltd Enhanced loading of intact, bacterially derived vesicles with small molecule compounds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0434960T3 (da) * 1989-12-19 1996-10-14 Pharmacia Spa Chirale 1,5-diiod-2-methoxy- eller benzyloxymellemprodukter
GB2296495B (en) * 1994-12-23 1998-04-15 Erba Carlo Spa Anthracycline derivatives
AU2592600A (en) * 1998-12-23 2000-07-31 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
GB9909925D0 (en) * 1999-04-29 1999-06-30 Pharmacia & Upjohn Spa Combined preparations comprising anthracycline derivatives

Also Published As

Publication number Publication date
WO2004082689A1 (en) 2004-09-30
AU2004222527A1 (en) 2004-09-30
EP1605951A1 (en) 2005-12-21
MXPA05009849A (es) 2005-12-06
CA2519310A1 (en) 2004-09-30

Similar Documents

Publication Publication Date Title
BRPI0415007A (pt) método para tratar, prevenir, modificar ou administrar dor, e, composição farmacêutica
BRPI0418029A (pt) formulação de anticorpos cd40 e métodos
BRPI0410503B8 (pt) composição tópica e uso da composição
BRPI0407897A (pt) derivados de cianopiridina úteis no tratamento de cáncer e outros distúrbios
AR034900A1 (es) Uso de una cantidad eficaz de un inhibidor de pde4 y un agente anticolinergico, bien en forma combinada sola o por separado, composiciones farmaceuticas que los comprenden, metodo para prepararlas, y uso de una composicion que comprende una cantidad eficaz de un inhibidor de pde4, una cantidad efica
MX2007006212A (es) Medicamento oral para liberacion modificada de al menos un principio activo bajo forma multimicrocapsular.
IL182352A0 (en) The use of et-743 in the preparation of a medicament for treating cancer and medical kits containing et-743
BR0316364A (pt) Combinação de terapia do câncer com um composto anticâncer ativado com gst e uma outra terapia anticâncer
BRPI0407234A (pt) Heterociclos substituìdos
WO2006050155A3 (en) Cancer therapeutic compositions
BRPI0413974A (pt) combinação, método de tratamento de cáncer em um animal de sangue quente, composição farmacêutica, e, uso de uma combinação
DK1383752T3 (da) Deutererede 3-piperidinopropiophenoner samt lægemidler indeholdende disse forbindelser
WO2006053049A3 (en) Herbal composition phy906 and its use in chemotherapy
MX2009011900A (es) Curacion de herida diabetica.
BRPI0511420A (pt) fosforodiamidatos de sulfoniletila
AR031761A1 (es) Kit de repinotano
WO2004100893A3 (en) Methods for treatment of inflammatory diseases using ct-3 or analogs thereof
CO5640094A2 (es) Una composicion farmaceutica que comprende un antagonista del receptor p2x7 y un factor alfa de necrosis de tumor
BRPI0408518A (pt) terapia combinada compreendendo nemorubicin e um inibidor de ciclooxigenase-2
WO2004014367A3 (en) Use of an amyloid beta vaccination in combination with a selective cox-2 inhibitor for the treatment of alzheimer's disease
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
BRPI0408944A (pt) método para fornecer um benefìcio de redução de esteróide com um inibidor de ciclooxigenase-2 e composições com este
PT1220676E (pt) Prevencao do cancro colorrectal
BRPI0415651A (pt) métodos para tratar, prevenir, modificar e/ou administrar fibromialgia, e para reduzir ou evitar um efeito adverso associado com a administração de um segundo ingrediente ativo em um paciente sofrendo de fibromialgia, e, composição farmacêutica

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]